Search results for: Multi-Indication Medicines

OHE at ISPOR Europe 2018

…medicines, and the approaches to address them. These challenges risk hindering the availability of life-changing treatments for children with rare diseases. Educational symposium: Indication-based Pricing; Who Wins, Who Loses, and…

International Comparison of Medicines Usage: Quantitative Analysis from a Swedish Perspective

1 May 2015

…different classes of medicines. In a majority of classes usage is below the two international averages. But while, for example, usage of cardiovascular medicines is low by international standards, use…

OHE Develops New, Bottom-Up Model for Forecasting UK Medicines Expenditure

3 April 2013

Medicines account for less than 10% of total NHS expenditure in the UK. Because spending on medicines is easy to separate out, however, this sector continues to come under particular…

OHE at ISPOR Washington DC (1): HTA, Evidence and Pricing

9 June 2016

…this issue panel; please see his slides below. Adrian presented a European perspective on multi-indication drug including options from an OHE supported stakeholder forum. “Multi-indication Pricing: Do we want it?…

OHE at HTAi Rome

12 July 2017

…Value Assessment of Multi-Indication Products: Practical Solutions and Steps. Adrian introduced the topic, noting that increasing numbers of new drugs have several indications. The challenge is to agree an efficient…

The Case of Risperidone: Assessing the Life-cycle Value of Second-Generation Antipsychotics in Sweden and the UK

1 July 2019

…medicines based on the example of Second-Generation Antipsychotics (SGA). Assessing the entire life-cycle of SGA, the study explores how much additional value has been delivered through additional approved indications for…

OHE at HTAi 2017: Meet the Team

13 June 2017

…countries, however their access is restricted by reimbursement policies (especially in the UK, Italy and Spain).  Panel: Value Assessment of Multi-Indication Products: Practical Solutions and Steps OHE Authors: Adrian Towse…

Recently Published: New Report Comparing Usage of Medicines in the UK with Other Countries

6 January 2015

…of medicines in the UK relative to 12 comparable high-income countries including France, Germany, Italy, Spain and the USA. Sixteen classes of medicines were included in the original Richards report…

The Impact of New Medicines in the NHS: 70 Years of Innovation

14 August 2018

…medicines in terms of health and economic outcomes. Our interviews with experts identified a shortlist of ten important new medicines introduced in the NHS in the last 70 years, which…